X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7606) 7606
Publication (629) 629
Book Review (70) 70
Book Chapter (20) 20
Book / eBook (7) 7
Newsletter (6) 6
Conference Proceeding (5) 5
Dissertation (5) 5
Data Set (3) 3
Magazine Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6231) 6231
antimetabolites, antineoplastic - pharmacology (3430) 3430
oncology (3084) 3084
index medicus (2947) 2947
animals (2740) 2740
female (2659) 2659
male (2544) 2544
antimetabolites, antineoplastic - therapeutic use (2079) 2079
cancer (1634) 1634
cell line, tumor (1543) 1543
mice (1541) 1541
chemotherapy (1527) 1527
deoxycytidine - analogs & derivatives (1522) 1522
middle aged (1453) 1453
pharmacology & pharmacy (1392) 1392
antimetabolites, antineoplastic - administration & dosage (1370) 1370
aged (1279) 1279
5-fluorouracil (1134) 1134
adult (1081) 1081
fluorouracil - pharmacology (1027) 1027
apoptosis (1019) 1019
antimetabolites, antineoplastic - pharmacokinetics (971) 971
tumor cells, cultured (912) 912
antimetabolites, antineoplastic - adverse effects (892) 892
expression (887) 887
apoptosis - drug effects (826) 826
gemcitabine (782) 782
fluorouracil - therapeutic use (764) 764
dose-response relationship, drug (740) 740
deoxycytidine - pharmacology (709) 709
rats (709) 709
fluorouracil (704) 704
antimetabolites, antineoplastic - metabolism (638) 638
drug resistance, neoplasm (632) 632
methotrexate (605) 605
biochemistry & molecular biology (604) 604
treatment outcome (597) 597
cell proliferation - drug effects (596) 596
therapy (564) 564
deoxycytidine - therapeutic use (559) 559
cell survival - drug effects (550) 550
azacitidine - pharmacology (536) 536
research (530) 530
pancreatic neoplasms - drug therapy (518) 518
fluorouracil - administration & dosage (517) 517
analysis (514) 514
mice, nude (491) 491
time factors (484) 484
care and treatment (481) 481
cells (479) 479
neoplasms - drug therapy (474) 474
pancreatic cancer (470) 470
azacitidine - analogs & derivatives (463) 463
aged, 80 and over (462) 462
dna methylation (456) 456
hematology (456) 456
blotting, western (448) 448
prognosis (444) 444
antineoplastic combined chemotherapy protocols - therapeutic use (440) 440
carcinoma (439) 439
colorectal neoplasms - drug therapy (437) 437
medicine & public health (435) 435
reverse transcriptase polymerase chain reaction (432) 432
cell biology (427) 427
tumors (423) 423
colorectal cancer (419) 419
toxicity (413) 413
pharmacokinetics (412) 412
gene expression (407) 407
drug synergism (403) 403
antineoplastic agents - pharmacology (400) 400
pancreatic neoplasms - pathology (394) 394
antimetabolites, antineoplastic - toxicity (386) 386
deoxycytidine - administration & dosage (380) 380
fluorouracil - pharmacokinetics (378) 378
pancreatic neoplasms - metabolism (376) 376
rna, messenger - metabolism (376) 376
gene expression regulation, neoplastic (373) 373
resistance (373) 373
capecitabine (369) 369
xenograft model antitumor assays (365) 365
inhibition (363) 363
thymidylate synthase (358) 358
metabolism (357) 357
leukemia (353) 353
article (350) 350
mice, inbred balb c (350) 350
in-vitro (346) 346
transfection (344) 344
child (343) 343
health aspects (340) 340
drug resistance (339) 339
gene expression regulation, neoplastic - drug effects (337) 337
proteins (334) 334
immunohistochemistry (332) 332
colorectal-cancer (330) 330
survival (330) 330
methotrexate - pharmacology (327) 327
cell division - drug effects (325) 325
fluorouracil - adverse effects (323) 323
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7313) 7313
Chinese (117) 117
Japanese (89) 89
French (25) 25
Russian (23) 23
German (22) 22
Italian (8) 8
Polish (6) 6
Spanish (6) 6
Hungarian (5) 5
Czech (4) 4
Norwegian (4) 4
Danish (2) 2
Korean (2) 2
Swedish (2) 2
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Kurdish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2011, Volume 89, Issue 3, pp. 387 - 391
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 3, pp. 664 - 674.e6
Background & Aims Patients who undergo surgery for pancreatic ductal adenocarcinoma (PDAC) frequently receive adjuvant gemcitabine chemotherapy. Key... 
Gastroenterology and Hepatology | Biomarker | Drug Metabolism | Pancreatic Cancer | Nucleoside Transporters | ADJUVANT CHEMOTHERAPY | MESSENGER-RNA EXPRESSION | RESECTION | SENSITIVITY | RANDOMIZED CONTROLLED-TRIAL | CELL LUNG-CANCER | RIBONUCLEOTIDE REDUCTASE | DEOXYCYTIDINE KINASE | EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1 | RESISTANCE | GASTROENTEROLOGY & HEPATOLOGY | Deoxycytidine Kinase - analysis | Immunohistochemistry | Multivariate Analysis | Pancreatic Neoplasms - chemistry | Humans | Male | Carcinoma, Pancreatic Ductal - surgery | Tissue Array Analysis - methods | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Deoxycytidine - metabolism | Biological Transport | Time Factors | Biotransformation | Carcinoma, Pancreatic Ductal - mortality | Female | Pancreatic Neoplasms - mortality | Retrospective Studies | Chemotherapy, Adjuvant | France | Antimetabolites, Antineoplastic - metabolism | Equilibrative Nucleoside Transporter 1 - analysis | Risk Assessment | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Risk Factors | Kaplan-Meier Estimate | Pancreatectomy | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - chemistry | Carcinoma, Pancreatic Ductal - drug therapy | Antimetabolites, Antineoplastic - therapeutic use | Deoxycytidine - analogs & derivatives | Tumor Suppressor Proteins - analysis | Adenocarcinoma | Medical research | Prognosis | Gemcitabine | Gastrointestinal agents | Patient outcomes | Biometry | Proteins | Chemotherapy | Pancreatic cancer | Nucleosides | Physiological aspects | Medicine, Experimental | Universities and colleges | Cancer | Analysis
Journal Article
ACS Nano, ISSN 1936-0851, 02/2017, Volume 11, Issue 2, pp. 1281 - 1291
Journal Article
Biosensors and Bioelectronics, ISSN 0956-5663, 06/2015, Volume 68, pp. 322 - 328
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 50, pp. 9 - 22
Highlights • Review on pharmacogenetic research to elucidate interpatient variations in capecitabine efficacy or toxicities • Current research has primarily... 
Hematology, Oncology and Palliative Medicine | Efficacy | Capecitabine | Toxicity | Genetic polymorphisms | CARBOXYLESTERASE-2 GENE | CYTIDINE DEAMINASE | ADVANCED COLORECTAL-CANCER | FLUOROPYRIMIDINE-ASSOCIATED TOXICITY | PREDICT RESPONSE | POLYMORPHISMS | ONCOLOGY | METASTATIC BREAST-CANCER | ADVANCED GASTRIC-CANCER | 1ST-LINE CAPECITABINE | THYMIDYLATE-SYNTHASE | Fluorouracil - metabolism | Genome-Wide Association Study | Pharmacogenetics | Capecitabine - metabolism | Cytidine Deaminase - genetics | Humans | Drug-Related Side Effects and Adverse Reactions - etiology | Methylenetetrahydrofolate Reductase (NADPH2) - metabolism | Capecitabine - therapeutic use | Carboxylesterase - metabolism | Neoplasms - drug therapy | Antimetabolites, Antineoplastic - therapeutic use | Capecitabine - adverse effects | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Cytidine Deaminase - metabolism | Drug-Related Side Effects and Adverse Reactions - genetics | Thymidine Phosphorylase - genetics | Antimetabolites, Antineoplastic - adverse effects | Carboxylesterase - genetics | Polymorphism, Single Nucleotide | Dihydrouracil Dehydrogenase (NADP) - metabolism | Thymidine Phosphorylase - metabolism | Antimetabolites, Antineoplastic - metabolism | Dihydrouracil Dehydrogenase (NADP) - genetics | Antimitotic agents | Antineoplastic agents
Journal Article
14.